CXCR4 and Familial prostate cancer: Taichman et al. demonstrated that CXCL12/SDF-1 (expressed by osteoblasts and endothelial cells) and its receptor (CXCR4, expressed by prostate cancer cells) regulate bone-tropism of prostate cancer cells [47].